PRMT1 and myocardial infarction: Furthermore, PRMT1 increases the production of ROS and NETs through the H1R-SWI/SNF-PRMT1-ROS pathway [51], which in turn promotes cardiomyocyte death and cardiac fibroblast proliferation, ultimately leading to the aggravation of MI.